Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells

Journal of Medical Virology

Volumn 80, Issue 1, 2008, Pages 134-146

  Kou, Zhihua ^a   Quinn, Matthew ^a   Chen, Huiyuan ^a   Rodrigo, W W Shanaka I ^a   Rose, Robert C ^a   Schlesinger, Jacob J ^a   Jin, Xia ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Dengue; Enhancement; Monocyte

Indexed keywords

CD14 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; B LYMPHOCYTE; CELL FRACTIONATION; DENGUE VIRUS; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INOCULATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; TARGET CELL; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS STRAIN;

B-LYMPHOCYTES; DENGUE; DENGUE VIRUS; HUMANS; LEUKOCYTES, MONONUCLEAR; MONOCYTES; T-LYMPHOCYTES;

DENGUE VIRUS;

EID: 36849074407     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21051     Document Type: Article

References (58)

1. Anderson MT, Baumgarth N, Haugland RP, Gerstein RM, Tjioe T, Herzenberg LA, Herzenberg LA. 1998. Pairs of violet-light-excited fluorochromes for flow cytometric analysis. Cytometry 33:435-444.
2. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161:6338-6346.
3. Baumgarth N, Roederer M. 2000. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 243:77-97.
4. Benne CA, Harmsen M, De Jong JC, Kraaijeveld CA. 1994. Neutralization enzyme immunoassay for influenza virus. J Clin Microbiol 32:987-990.
5. Bigos M, Baumgarth N, Jager GC, Herman OC, Nozaki T, Stovel RT, Parks DR, Herzenberg LA. 1999. Nine color eleven parameter immunophenotyping using three laser flow cytometry. Cytometry 36:36-45.
6. Brown MG, King CA, Sherren C, Marshall JS, Anderson R. 2006. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol 80:1242-1250.
7. Chen YC, Wang SY. 2002. Activation of terminally differentiated human monocytes/macrophages by dengue virus: Productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76:9877-9887.
8. De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 2001. 11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 7:245-248.
9. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74:7814-7823.
10. Dougherty GJ, Selvendran Y, Murdoch S, Palmer DG, Hogg N. 1987. The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur J Immunol 17:1453-1459.
11. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964.
12. Green S, Rothman A. 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19:429-436.
13. Halstead SB. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42:350-362.
14. Halstead SB. 1980. Immunological parameters of togavirus disease syndromes. In: Schlesinger RW, editor. The togaviruses - Biology, structure, replication. New York: Academic Press, pp 107-173.
15. Halstead SB. 1988. Pathogenesis of dengue: Challenges to molecular biology. Science 239:476-481.
16. Halstead SB. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade. Rev Infect Dis 11:S830-S839.
17. Halstead SB, Marchette NJ. 2003. Biologic properties of dengue viruses following serial passage in primary dog kidney cells: Studies at the University of Hawaii. Am J Trop Med Hyg 69:5-11.
18. Halstead SB, O'Rourke EJ. 1977a. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739-741.
19. Halstead SB, O'Rourke EJ. 1977b. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing anti-body. J Exp Med 146:201-217.
20. Halstead SB, Marchette NJ, Sung Chow JS, Lolekha S. 1976. Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings. Proc Soc Exp Biol Med 151:136-139.
21. Halstead SB, O'Rourke EJ, Allison AC. 1977. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med 146:218-229.
22. Halstead SB, Heinz FX, Barrett AD, Roehrig JT. 2005. Dengue virus: Molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine 23:849-856.
23. Hotta H, Wiharta AS, Hotta S, Homma M. 1984. Dengue type 2 virus infection in human peripheral blood monocyte cultures. Microbiol Immunol 28:1099-1109.
24. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63:71-75.
25. King AD, Nisalak A, Kalayanrooj S, Myint KS, Pattanapanyasat K, Nimmannitya S, lnnis BL. 1999. B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health 30:718-728.
26. Kliks S. 1990. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses 6:993-998.
27. Kliks SC, Halstead SB. 1980. An explanation for enhanced virus plaque formation in chick embryo cells. Nature 285:504-505.
28. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38:411-419.
29. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444-451.
30. Kontny U, Kurane I, Ennis FA. 1988. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 62:3928-3933.
31. Kurane I, Ennis FA. 1988. Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol 69:445-449.
32. Kurane I, Kontny U, Janus J, Ennis FA. 1990. Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol 110:91-101.
33. Lambeth CR, White LJ, Johnston RE, de Silva AM. 2005. Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 43:3267-3272.
34. Lin YW, Wang KJ, Lei HY, Lin YS, Yeh TM, Liu HS, Liu CC, Chen SH. 2002. Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol 76:12242-12249.
35. Littaua R, Kurane I, Ennis FA. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144:3183-3186.
36. Mackenzie JS, Gubler DJ, Petersen LR. 2004. Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10:S98-S109.
37. Mangada MM, Rothman AL. 2005. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175:2676-2683.
38. Mangada MM, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Libraty DH, Green S, Ennis FA, Rothman AL. 2002. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 185:1697-1703.
39. Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A, Deubel V. 1999. Infection of primary cultures of human Kupffer cells by Dengue virus: No viral progeny synthesis, but cytokine production is evident. J Virol 73:5201-5206.
40. Martin NC, Pardo J, Simmons M, Tjaden JA, Widjaja S, Marovich MA, Sun W, Porter KR, Burgess TH. 2006. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies. J Virol Methods 134:74-85.
41. Mentor NA, Kurane I. 1997. Dengue virus infection of human T lymphocytes. Acta Virol 41:175-176.
42. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921-927.
43. Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G. 2006. T cell responses in dengue hemorrhagic fever: Are cross-reactive T cells suboptimal? J Immunol 176:3821-3829.
44. Moreno-Altamirano MMB, Romano M, Legorreta-Herrera M, Sanchez-Garcia FJ, Colston MJ. 2004. Gene expression in human macrophages infected with dengue virus serotype-2. Scand J Immunol 60:631-638.
45. Morens DM, Halstead SB. 1990. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 71:2909-2914.
46. O'Sullivan MA, Killen HM. 1994. The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus. J Gen Virol 75:2387-2392.
47. Porterfield JS. 1980. In: Schlesinger RW, editor. The togaviruses - Biology, structure, replication. New York: Academic Press, pp 13-42.
48. Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ. 2006. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fc{gamma}RIA (CD64) or Fc{gamma}RIIA (CD32). J Virol 80:10128-10138.
49. Rothman AL. 2004. Dengue: Defining protective versus pathologic immunity. J Clin Invest 113:946-951.
50. Russell PK, Nisalak A. 1967. Dengue virus identification by the plaque reduction neutralization test. J Immunol 99:291-296.
51. Russell PK, Nisalak A, Sukhavachana P, Vivona S. 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99:285-290.
52. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA. 2003. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197:823-829.
53. Theofilopoulos AN, Brandt WE, Russell PK, Dixon FT. 1976. Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol 117:953-961.
54. Thepparit C, Smith DR. 2004. Serotype-specific entry of dengue virus into liver cells: Identification of the 37-Kilodalton/67-Kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 78:12647-12656.
55. van de Winkel JG, Anderson CL. 1991. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 49:511-524.
56. Welsh RM, Rothman AL. 2003. Dengue immune response: Low affinity, high febrility. Nat Med 9:820-822.
57. Wilder-Smith A, Schwartz E. 2005. Dengue in travelers. N Engl J Med 353:924-932.
58. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6:816-820.